| Literature DB >> 21209173 |
Joshua R Shak1, Jennifer A Whitaker, Bruce S Ribner, Eileen M Burd.
Abstract
Amikacin is a first-line treatment for Aeromonas infection due to high efficacy. There are few reports of aminoglycoside-resistant Aeromonas spp. We report a soft tissue infection containing multiple pathogens, including a strain of Aeromonas hydrophila resistant to amikacin, tobramycin, and multiple cephalosporins.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21209173 PMCID: PMC3067704 DOI: 10.1128/JCM.01949-10
Source DB: PubMed Journal: J Clin Microbiol ISSN: 0095-1137 Impact factor: 5.948